je.st
news
Tag: combination
RockTenn Shareholders and MWV Stockholders Approve Combination
2015-06-25 20:17:50| Paper - Topix.net
June 25, 2015 - Rock-Tenn and MeadWestvaco late yesterday announced that shareholders of RockTenn and stockholders of MWV overwhelmingly approved the proposed combination of the two packaging companies into WestRock Company at their respective special meetings held earlier that day. At the RockTenn special meeting, more than 97% of the shares voted "FOR" the proposal to approve the business combination agreement, representing approximately 80% of the total shares outstanding as of the record date.
Tags: combination
approve
stockholders
shareholders
Seattle biotechs flock to Philadelphia to talk combination therapies, partnering with big pharma
2015-06-20 02:17:46| Biotech - Topix.net
Biotech industry leaders from around the world descended on Philadelphia this week to talk about the future direction of the industry. The Biotechnology Industry Organization's 2015 International BIO Convention brought together more than 2,500 CEOs and 15,000 attendees, and Seattle's biotech scene is well-represented there.
Tags: big
talk
combination
philadelphia
Combination Tool pairs functionality of pliers and wrench.
2015-06-02 14:31:06| Industrial Newsroom - All News for Today
Featuring pocket-sized, 5 in. design, KNIPEX Pliers Wrench Mini facilitates gripping, holding, pressing, and bending. All-in-one tool provides full-surface gripping capacity up to 7/8 in. and eliminates need for SAE or metric wrenches. Offering pushbutton adjustment and ratcheting action, tool stays in place for fast turns on repetitive tasks. Tool is constructed from German, chrome-vanadium electric steel, forged and oil-hardened, with smooth parallel jaws that will not damage workpiece.
Tags: tool
combination
functionality
pairs
Merck and Dynavax Announce New Collaboration Investigating the Combination of Immuno-Oncology Therapies
2015-06-01 14:30:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. & BERKELEY, Calif. Studies to Evaluate the Combination of Dynavaxs SD-101 with Two Immunotherapies from Mercks Pipeline, KEYTRUDA (pembrolizumab) and MK-1966 Collaboration Includes First-in-human Study for MK-1966, a New Investigational Anti-interleukin-10 (anti-IL-10) Immunomodulator from Mercks Rapidly Growing Immuno-oncology Pipeline KENILWORTH, N.J. Language: English Contact: Merck Media Relations:Pamela Eisele, 267-664-0282Claire Mulhearn, 908-200-1889orMerck Investor Relations:Justin Holko, 908-740-1879orDynavax Investor/Media Relations:Michael Ostrach, 510-665-7257 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: combination
collaboration
announce
investigating
Zydelig in Combination With Ofatumumab Improves Progression-Free...
2015-05-31 19:33:26| Biotech - Topix.net
Phase 3 Study Results Showing 73 Percent Reduction versus Ofatumumab Alone in Risk of Disease Progression or Death to be Presented at American Society of Clinical Oncology Annual Meeting -- CHICAGO-- -- Gilead Sciences, Inc. today announced results from the Phase 3 clinical Study 119 of an investigational use of ZydeligA in combination with ofatumumab in previously-treated patients with chronic lymphocytic leukemia . In Study 119, there was a 73 percent reduction in the risk of disease progression or death in patients receiving Zydelig in combination with ofatumumab compared to ofatumumab alone = 0.27; 95 percent CI: 0.19, 0.39; p<0.0001).
Tags: combination
improves
progressionfree
ofatumumab
Sites : [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] next »